Nice one will be back down.. Amemocyte itself does not appear to be directly generating significant revenue or profit. Its partner, Humacyte, has launched products and reported some revenue, but the revenue figures are modest and the company still incurs operating losses due to ongoing costs in development and commercialization. For example, Humacyte's total revenue for Q1 2025 was $517,000, with operating expenses much higher, resulting in a loss from operations of about $23.18 million...
Market Data 
Markets 
AI
